Nephro Care India IPO Opens June 28 at Rs 85-90/share

By By Rediff Money Desk, New Delhi
Jun 25, 2024 13:44
Nephro Care India's IPO opens June 28, aiming to raise over Rs 41 crore. The price band is set at Rs 85-90 per share, with the IPO closing on July 2. The funds will be used for a new multi-speciality hospital in Kolkata.
New Delhi, Jun 25 (PTI) Kidney care provider Nephro Care India Ltd on Tuesday said it is looking to raise a little over Rs 41 crore through its initial share-sale, which will open for public subscription on June 28.

The issue, with a price band of Rs 85-90 per share, will conclude on July 2. The bidding for anchor investors will open for a day on June 27, the Kolkata-headquartered healthcare provider said in a statement.

The IPO comprises fresh issuance of 45.84 lakh equity shares worth Rs 41.26 crore at the upper-end of the price band. Post-issue, shares of the company will be listed on the NSE Emerge platform.

The kidney care provider intends to utilise Rs 26.17 crore of the IPO proceeds for setting-up a multi-speciality healthcare facility -- Vivacity Multi Speciality Hospital -- at Madhyamgram in Kolkata, West Bengal, and the remaining capital will be used for general corporate purposes.

The new hospital is proposed to include 100 in-patient beds, including a 30-bed Critical Care unit. The new hospital will offer treatment services in various disciplines such as cardiology, medical oncology, gastroenterology, gynaecology and many others, including an advanced renal transplant unit in East India.

In December 2023, Nephro Care India successfully closed the pre-IPO funding round, which saw the participation of banking veteran and former chairman of HDFC Ltd Deepak Parekh, chairman of HDFC Securities Bharat Shah, and Founder and MD of Macleods Pharmaceuticals Rajendra Agarwal among others.

In terms of financials, Nephro Care India posted a revenue of Rs 19.75 crore and earned a profit (PAT) of Rs 3.4 crore during the first nine months of FY 2023-24.

Corporate Capital Ventures is the book-running lead manager and Bigshare Services Private Ltd is the registrar for the issue.
Source: PTI
Read More On:
nephro care indiaipoinitial public offeringhealthcarekidney carekolkatawest bengalmulti-speciality hospitalvivacity multi speciality hospitalmadhyamgramdeepak parekhhdfcbharat shahmacleods pharmaceuticalsrajendra agarwalcorporate capital venturesbigshare services private ltd
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

India Aims for 89 Mtoe Energy Reduction by 2030

India's government has unveiled a plan to cut energy consumption by 89 million tonnes...

India May Attract Global Manufacturers with Low...

India's lower tariffs could attract global manufacturers, boosting demand for...

Advance Agrolife Files IPO Draft Papers with Sebi

Agrochemical firm Advance Agrolife Ltd has filed IPO papers with Sebi, seeking to raise...

Airbnb India Growth: 30% Surge in Last Fiscal Year

Airbnb reports a significant 30% growth in India during the last fiscal year, driven by...

Jindal Steel Acquires Allied Strips for Rs 217 Cr

Jindal Steel and Power Ltd (JSPL) acquires Allied Strips Limited (ASL) for over Rs 217...

Trump Tariffs Won't Hurt Indian Auto Industry:...

The latest US tariffs are unlikely to impact the Indian auto industry due to low...

Poonam Gupta Appointed RBI Deputy Governor

Poonam Gupta, Director General of NCAER, has been appointed as Deputy Governor of RBI...

Divine Power Energy Acquires Vimlesh Industries...

Divine Power Energy Ltd (DPEL) has completed the acquisition of Vimlesh Industries for...

Sebi Exempts Govt From Open Offer for Vodafone...

Sebi has exempted the government from making an open offer to Vodafone Idea...

India, US Expedite Talks for Bilateral Trade...

India and the US are accelerating negotiations for a bilateral trade agreement, aiming...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com